First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors GBX 1,475.60 +12.00 (+0.82%) As of 07/2/2025 11:35 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock FBT vs. PRSM, KAPE, TRST, KNOS, LTG, ALFA, GBG, ATG, IMO, and NCCShould you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Blue Prism Group (PRSM), Kape Technologies (KAPE), Trustpilot Group (TRST), Kainos Group (KNOS), Learning Technologies Group (LTG), Alfa Financial Software (ALFA), GB Group (GBG), Auction Technology Group (ATG), IMImobile (IMO), and NCC Group (NCC). These companies are all part of the "software - application" industry. First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. Its Competitors Blue Prism Group Kape Technologies Trustpilot Group Kainos Group Learning Technologies Group Alfa Financial Software GB Group Auction Technology Group IMImobile NCC Group Blue Prism Group (LON:PRSM) and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability. Is PRSM or FBT more profitable? Company Net Margins Return on Equity Return on Assets Blue Prism GroupN/A N/A N/A First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation N/A N/A N/A Does the media favor PRSM or FBT? In the previous week, Blue Prism Group's average media sentiment score of 0.00 equaled First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation'saverage media sentiment score. Company Overall Sentiment Blue Prism Group Neutral First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Neutral Which has preferable earnings and valuation, PRSM or FBT? First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Blue Prism Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBlue Prism Group£167.30M0.00N/A-£53.80N/AFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,341.45 SummaryBlue Prism Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 2 of the 3 factors compared between the two stocks. Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBT vs. The Competition Export to ExcelMetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON ExchangeMarket Cap£605.31M£5.37B£27.19B£2.96BDividend YieldN/A3.24%3.15%5.02%P/E Ratio-1,341.4528.4335.99148.22Price / SalesN/A318.321,939.20277,425.18Price / Cash3.5416.6337.6527.97Price / BookN/A9.347.075.28Net IncomeN/A£64.18M£763.02M£5.90B7 Day Performance2.79%0.68%1.86%0.11%1 Month Performance0.90%4.80%5.94%4.65%1 Year Performance1.60%10.99%52,289.36%80.39% First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBTFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AGBX 1,475.60+0.8%N/A-0.1%£605.31MN/A-1,341.4520PRSMBlue Prism GroupN/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading VolumeKAPEKape TechnologiesN/AN/AN/AN/A£1.22B£623.48M1,900.00850Gap DownTRSTTrustpilot Group0.68 of 5 starsGBX 232.40+0.5%GBX 290+24.8%+5.0%£1.22B£222.55M77.04820KNOSKainos Group3.511 of 5 starsGBX 755+0.7%GBX 1,078.33+42.8%-31.4%£953.65M£383.18M19.782,953LTGLearning Technologies GroupN/AN/AGBX 90+∞N/A£792.10M£529.20M16.755,001ALFAAlfa Financial SoftwareN/AGBX 222.50+0.7%N/A+16.9%£666.34M£103.11M30.08475Gap UpGBGGB GroupN/AGBX 235+0.4%N/A-34.7%£592.73M£276.95M-12.201,183Positive NewsATGAuction Technology Group1.6203 of 5 starsGBX 441-0.1%GBX 680+54.2%+3.2%£544.79M£136.68M53.86396News CoverageIMOIMImobileN/AN/AN/AN/A£490.40M£164.04M123.755,300NCCNCC GroupN/AGBX 144.20+0.6%N/A-8.8%£454.63M£326.70M-18.162,200Dividend Cut Related Companies and Tools Related Companies Blue Prism Group Competitors Kape Technologies Competitors Trustpilot Group Competitors Kainos Group Competitors Learning Technologies Group Competitors Alfa Financial Software Competitors GB Group Competitors Auction Technology Group Competitors IMImobile Competitors NCC Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FBT) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBT Stock Alerts